August 4, 2023
A new study published by UNC Family Medicine’s Sarah Kowitt, PhD, MPH, and colleagues looked at the impact of different types of warning signs for large and premium cigars sold individually at the point of sale. The team’s newly developed graphic and text warnings were more effective than the FDA’s proposed text-only warnings and could potentially increase the effectiveness of warning signs for large and premium cigars.
July 31, 2023
Researchers in UNC School of Medicine’s Department of Otolaryngology/Head and Neck Surgery and collaborators at Yale Cancer Center and ECOG-ACRIN Cancer Research Group have identified two subtypes of human papillomavirus positive head and neck cancers, giving them a better glimpse into why some patients respond better to treatment than others.
July 6, 2023
Washington, N.C man with squamous cell carcinoma of the tongue experiences positive life-changing results after participating in an induction therapy clinical trial at the UNC School of Medicine.
May 12, 2023
Jennifer S. Smith, PhD, at the UNC Gillings School of Global Public Health, UNC School of Medicine, and UNC Lineberger Comprehensive Cancer Center, led the phase 3 controlled trial, which showed that self-collection kits and scheduling assistance are key for reaching these populations and preventing cervical cancer.
February 20, 2023
UNC School of Medicine researchers Jack Griffith, PhD, and Taghreed Al-Turki, PhD, found that telomeres at the tips of chromosomes contain sufficient genetic information to produce two small proteins with potentially potent biological properties.
February 6, 2023
Led by researchers in the UNC School of Medicine lab of Blossom Damania, PhD, a study in Nature Communications shows how Kaposi sarcoma-associated herpesvirus and Epstein-Barr virus hijack a human protein to help the viruses evade innate immune detection to spread undeterred.
January 30, 2023
Carla Chibwesha, MD, MSc, an associate professor of obstetrics and gynecology in the University of North Carolina’s Division of Global Women’s Health and the UNC Lineberger Comprehensive Cancer Center, will work with researchers at Weill Cornell Medicine and Moffitt Cancer Center develop trials to be conducted at clinical sites in Kenya, Uganda and Botswana.
December 19, 2022
Led by Jessica Thaxton, PhD, MsCR, UNC School of Medicine scientists and colleagues found that targeting key proteins that control the T cell response to stress could help researchers develop more potent cancer immunotherapies.
December 12, 2022
With expanded hours and telemedicine visits, the Integrative and Lifestyle Medicine Consultation Clinic serves patients affected by cancer across the UNC Health System.
December 8, 2022
UNC Health is leading the way in glioblastoma treatment with a new clinical trial. The study will evaluate the safety and tolerability of CAR-T immunotherapy in patients with recurrent or progressive glioblastoma.
November 21, 2022
A new glioblastoma treatment from Northwest Biotherapeutics improved outcomes for many patients in a phase 3 clinical study, according to a study published in JAMA Oncology. Matt Ewend, MD, in the UNC Department of Neurosurgery and at UNC Lineberger, led the trial site at the N.C. Basnight Cancer Hospital.
September 12, 2022
The article by Marc Bjurlin, DO, associate professor of urology, is one of a series of publications that is originating from new collaborations between UNC'S Department of Urology and the UNC Tobacco Treatment Program.